DOI: 10.1055/s-00000054

Pharmacopsychiatry

References

Preskorn SH, Baker B, Kolluri S. et al.
An innovative design to establish proof of concept of the antidepressant effects of the NR2B subunit selective n-methyl-d-aspartate antagonist, CP-101,606, in patients with treatment-refractory major depressive disorder.

J Clin Psychopharmacol 2008;
28: 631-637

Download Bibliographical Data

Access:
Access: